Concepedia

Shaoyi Sun

SS

Statistics

Publications

16

Citations

447

H-Index

14

Active since

1999

Affiliations

Xenon Pharmaceuticals (Canada)(Current)

University of Alberta

Novartis (United States)

Shanghai Zhangjiang Laboratory

Novartis (China)

Shaoyi Sun is an author at Xenon Pharmaceuticals (Canada) specializing in medicinal chemistry, pharmacology, and drug discovery.

ORCID

Publications per year

1999–2021

16

Publications

16

A versatile copper-catalyzed coupling reaction of pyridin-2(1H)-ones with aryl halides

Kevin J. Filipski, Jeffrey T. Kohrt, Agustin Casimiro‐Garcia et al. · Tetrahedron Letters · 2006 · 57 citations

, , +10

Discovery of Acyl-sulfonamide Na<sub>v</sub>1.7 Inhibitors GDC-0276 and GDC-0310

Brian S. Safina, Steven J. McKerrall, Shaoyi Sun et al. · Journal of Medicinal Chemistry · 2021 · 39 citations · Full text

, , +12

The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Nav1.7

Shaoyi Sun, Qi Jia, Alla Zenova et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 36 citations · Full text

, , +16

Tetracyclic spirooxindole blockers of hNaV1.7: activity in vitro and in CFA-induced inflammatory pain model

Sultan Chowdhury, Shifeng Liu, Jay A. Cadieux et al. · Medicinal Chemistry Research · 2012 · 36 citations

, , +12

Identification of Selective Acyl Sulfonamide–Cycloalkylether Inhibitors of the Voltage-Gated Sodium Channel (Na <sub>V</sub> ) 1.7 with Potent Analgesic Activity

Shaoyi Sun, Qi Jia, Alla Zenova et al. · Journal of Medicinal Chemistry · 2018 · 35 citations · Full text

, , +17

1–5 of 16